The global Genomics Market was valued at USD 13.2 billion in 2016 and is projected to reach USD 30.59 billion by 2025, growing at a CAGR of 9.78% from 2017 to 2025.
Genomics is sequencing based technology which relies on finding out the nucleotide bases coupling and placement of DNA or genetic material of target organism or patient. The sequences are utilized in diverse ways, either in Healthcare and Pharmaceutical sector or in Gene therapy and Research Projects of evolutionary Biology.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Growth and funds for Genomics projects
1.2 Growing demand due to less sequencing costs
1.3 Growing demands and applications of genomics in Healthcare
1.4 New company launches in Genomics sector of biotech and Bioinformatics
2. Market Restraints
2.1 High equipment cost
Market Segmentation:
1. Global Genomics Market, by Technology:
1.1 Sequencing
1.2 Microarray
1.3 PCR
1.4 Nucleic Acid Extraction and Purification
1.5 Other Technologies
2. Global Genomics Market, by Products and Services:
2.1 Instruments and Systems
2.2 Consumables
2.3 Services
3. Global Genomics Market, by Application:
3.1 Diagnostics
3.1.1 Cancer Diagnostics
3.1.2 Monogenic (Mendelian) Disorders
3.1.3 Other Diagnostic Applications
3.1.3.1 Common Diseases and Complex Disorders
3.1.3.2 Movement Disorders
3.1.3.3 HIV
3.2 Drug Discovery and Development
3.3 Precision Medicine
3.4 Agriculture & Animal Research
3.5 Other Applications
4. Global Genomics Market, by Process:
4.1 Sequencing
4.2 Library Preparation
4.3 Data Analysis
5. Global Genomics Market, by End User:
5.1 Research Centers and Academic & Government Institutes
5.2 Hospitals and Clinics
5.3 Pharmaceutical & Biotechnology Companies
5.4 Other End Users
6. Global Genomics Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Illumina
2. Agilent Technologies
3. Thermo Fisher Scientific
4. Eurofins Scientific
5. Qiagen
6. GE Healthcare
7. F. Hoffmann-La Roche
8. Oxford Nanopore Technologies
9. Bio-Rad Laboratories
10. BGI
11. Eppendorf
12. Pacific Biosciences of California
13. Danaher
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Genomics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL GENOMICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL GENOMICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY
5.1 Overview
5.2 Sequencing
5.3 Microarray
5.4 PCR
5.5 Nucleic Acid Extraction and Purification
5.6 Other Technologies
6 GLOBAL GENOMICS MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Instruments and Systems
6.3 Consumables
6.4 Services
7 GLOBAL GENOMICS MARKET, BY APPLICATION
7.1 Overview
7.1.1 Diagnostics
7.1.2 Cancer Diagnostics
7.1.3 Monogenic (Mendelian) Disorders
7.1.4 Other Diagnostic Applications
7.1.4.1 Common Diseases and Complex Disorders
7.1.4.2 Movement Disorders
7.1.4.3 HIV
7.2 Drug Discovery and Development
7.3 Precision Medicine
7.4 Agriculture & Animal Research
7.5 Other Applications
8 GLOBAL GENOMICS MARKET, BY PROCESS
8.1 Overview
8.2 Sequencing
8.3 Library Preparation
8.4 Data Analysis
9 GLOBAL GENOMICS MARKET, BY END USER
9.1 Overview
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals and Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users
10 GLOBAL GENOMICS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
11 GLOBAL GENOMICS MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Illumina
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Agilent Technologies
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Thermo Fisher Scientific
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Eurofins Scientific
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Qiagen
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 GE Healthcare
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 F. Hoffmann-La Roche
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Oxford Nanopore Technologies
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Bio-Rad Laboratories
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 BGI
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
12.11 Eppendorf
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments
12.12 Pacific Biosciences of California
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments
12.13 Danaher
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments
13 Appendix
13.1 Related Reports
The Agriculture Genomics Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/...
The Genomics Data Analysis Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The global Genomics Biomarkers market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Genomics Personalized Health market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
The global Spatial Genomics & Transcriptomics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...
Overview of the Global Functional Genomics In Plants Market:
The report discusses everything a marketer requires before investing in the global Functional Genomics In Plants Market during the forecast period 2023-20...
Overview of the Global Genomics Biomarker Services Market:
The report discusses everything a marketer requires before investing in the global Genomics Biomarker Services Market during the forecast period 2023-2030. ...
Overview of the Global Genomics-guided Therapy Biosimulation Platform Market:
The report discusses everything a marketer requires before investing in the global Genomics-guided Therapy Biosimulation Platform Market ...
Overview of the Global Integrated Genomics Data Solutions Market:
The report discusses everything a marketer requires before investing in the global Integrated Genomics Data Solutions Market during the forecast peri...
The global Genomics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evalu...